The notices it replaced
Its page names no earlier notice: it is new, or it does not say.
Replaced by RFA-HL-20-012.
Who won it before
19 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $14,089,251 in first-year total cost, median $788,750.
Most frequent study sections
- Special Emphasis Panel[ZHL1 CSR-I (O2)]19
Most frequent institutions
- UNIVERSITY OF ALABAMA AT BIRMINGHAM2
- CINCINNATI CHILDRENS HOSP MED CTR1
- EMORY UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- MEDICAL COLLEGE OF WISCONSIN1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia1R35HL144805-01 | EVANS, SCOTT E. | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $893,554 | ZHL1 |
| 2019 | Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis1R35HL144475-01 | LEEPER, NICHOLAS JAMES | STANFORD UNIVERSITY, CA | $853,060 | ZHL1 |
| 2019 | Protease-Mediated Vascular Instability in Development and Disease1R35HL144605-01 | GRIFFIN, COURTNEY T | OKLAHOMA MEDICAL RESEARCH FOUNDATION, OK | $844,478 | ZHL1 |
| 2019 | Diagnosis, Prevention, And Treatment Of Cardiovascular Diseases With Genome Editing1R35HL145203-01 | MUSUNURU, KIRAN | UNIVERSITY OF PENNSYLVANIA, PA | $808,333 | ZHL1 |
| 2019 | Targeted Molecular Probes for Atherosclerosis Imaging and Therapy1R35HL145212-01 | LIU, YONGJIAN | WASHINGTON UNIVERSITY, MO | $742,659 | ZHL1 |
| 2019 | Mechanisms of Platelet Activity in Vascular Disease1R35HL144993-01 | BERGER, JEFFREY S | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $597,921 | ZHL1 |
| 2019 | Engineering biophysical microtechnologies for hematologic applications in health and disease1R35HL145000-01 | LAM, WILBUR A | EMORY UNIVERSITY, GA | $401,322 | ZHL1 |
| 2018 | Precision Medicine in the Acute Respiratory Distress Syndrome1R35HL140026-01 | CALFEE, CAROLYN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $986,596 | ZHL1 |
| 2018 | Systematic Investigation of Protein Ubiquitination in ARDS1R35HL139860-01 | CHEN, BEIBEI | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $858,906 | ZHL1 |
| 2018 | Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation1R35HL139926-01 | CHAUHAN, ANIL KUMAR | UNIVERSITY OF IOWA, IA | $758,840 | ZHL1 |
| 2018 | Lung Macrophage Programming in Acute Lung Injury1R35HL140039-01 | JANSSEN, WILLIAM | NATIONAL JEWISH HEALTH, CO | $553,487 | ZHL1 |
| 2017 | Translational Program in CFTR-Related Airway Diseases1R35HL135816-01 | ROWE, STEVEN MARK | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $930,091 | ZHL1 |
| 2017 | Using Genetics to Inform Mechanism of Cardiovascular Disease1R35HL135824-01 | WILLER, CRISTEN J | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $902,064 | ZHL1 |
| 2017 | Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis1R35HL135820-01 | FERNANDEZ HERNANDO, CARLOS | YALE UNIVERSITY, CT | $850,059 | ZHL1 |
| 2017 | Decoding innate immune signaling in normal and myelodysplastic hematopoiesis1R35HL135787-01 | STARCZYNOWSKI, DANIEL | CINCINNATI CHILDRENS HOSP MED CTR, OH | $788,750 | ZHL1 |
| 2017 | Mechanobiology of Cardiopulmonary Fibrosis1R35HL135790-01 | MERRYMAN, WILLIAM D | VANDERBILT UNIVERSITY, TN | $764,131 | ZHL1 |
| 2017 | Program on cellular metabolism and lung fibrosis1R35HL135830-01 | LIU, GANG | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $742,500 | ZHL1 |
| 2017 | Cardiovascular Development and Regeneration in Zebrafish1R35HL135831-01 | BURNS, CAROLINE E | MASSACHUSETTS GENERAL HOSPITAL, MA | $427,500 | ZHL1 |
| 2017 | Renal ion channels in the control of blood pressure1R35HL135749-01 | STARUSCHENKO, ALEXANDER | MEDICAL COLLEGE OF WISCONSIN, WI | $385,000 | ZHL1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.